Biocon Ranks 13th Among World's Top 20 Biopharma Employers in Science Magazine's 2026 Survey

The recognition highlights Biocon's standing as an employer of choice in the global life sciences industry. Since making its debut on the prestigious Science Careers Top Employers list in 2012, the Bengaluru-headquartered biopharmaceutical company has consistently featured among leading employers in the sector.

In the 2026 survey, Biocon received recognition for three key attributes: social responsibility, respect for employees and a workplace culture aligned with employee values.

Shreehas Tambe, CEO and Managing Director of Biocon, said the recognition marked the company's 15th consecutive year among the world's leading biopharmaceutical employers.

He attributed the achievement to the talent, dedication and commitment of Biocon's workforce, adding that the company believes scientific progress begins with its people.

As Biocon advances its ambition to become a fully integrated global medicines company, it remains focused on building a workplace culture that promotes innovation, excellence and collaboration while supporting its mission of delivering life-changing medicines to patients worldwide.

The company's people-centric culture continues to strengthen its global employer brand. Its workforce represents 37 nationalities across more than 60 cities worldwide, bringing diverse perspectives and expertise to its operations.

Survey Evaluates Global Life Sciences Employers

The Science and Science Careers 2026 Top Employers Survey assessed companies across biotechnology, biopharmaceutical, pharmaceutical and related industries to identify the 20 leading employers and the attributes driving their reputation.

Participants were asked to evaluate companies against 24 characteristics covering areas such as corporate image, financial strength, leadership and direction, and workplace culture and environment.

The rankings were based on approximately 5,100 completed surveys and were analysed by the US-based Brighton Consulting Group, an independent research firm commissioned by the Science/AAAS Office of Publishing.

Most respondents were based in North America (71%), followed by Europe (19%) and Asia-Pacific (6%). The survey used a mathematical methodology to identify the key characteristics of leading employers and assign scores reflecting their employer reputation.

Biocon Limited is a global biopharmaceutical company headquartered in Bengaluru, India, focused on developing and delivering affordable medicines for patients worldwide.

The company operates across biosimilars and generics, addressing major healthcare needs in therapy areas including diabetes, oncology, obesity, cardiovascular diseases, immunology, ophthalmology and bone health.

Biocon has commercialised 12 biosimilar products and more than 30 generic formulations globally. Its research and development pipeline includes over 20 biosimilar assets, GLP-1 peptides and other complex generics.

With operations in more than 120 countries, the company is supported by seven manufacturing sites, three research and development facilities and 18 offices worldwide. It has a workforce of more than 9,500 employees.

Biocon was also included in the S&P Global Sustainability Yearbook 2026 for the fourth consecutive year, reflecting its continued focus on sustainable and responsible growth.